Clinical Trials · NCT02721888
Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Enrollment
- 127
- Start date
- Jul 2012
- Locations
- 1 site, France
- Primary endpoint
- Effect of liraglutide on fatty liver content evaluated by proton-spectroscopy (1H-spectroscopy and lipoprotein kinetics, in patients with type 2 diabetes